+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Response, toxicity, failure patterns and survival in five radiation therapy oncology group trials of sequential and/or concurrent chemotherapy and radiation therapy for locally advanced non-small cell carcinoma of the lung



Response, toxicity, failure patterns and survival in five radiation therapy oncology group trials of sequential and/or concurrent chemotherapy and radiation therapy for locally advanced non-small cell carcinoma of the lung



International Journal of Radiation Oncology Biology Physics 39(2 Suppl. ): 195




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033215855

Download citation: RISBibTeXText


Related references

Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. International Journal of Radiation Oncology Biology Physics 42(3): 469-478, 1998

Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung. International Journal of Radiation Oncology, Biology, Physics 84(2): 456-463, 2012

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung Analysis of radiation therapy oncology group trials. International Journal of Radiation Oncology Biology Physics 43(3): 505-509, Feb 1, 1999

Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): Analysis of radiation therapy oncology group (RTOG) trials. International Journal of Radiation Oncology Biology Physics 43(3): 505-509, 1999

Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database. Clinical Lung Cancer 12(4): 245-251, 2011

The treatment of unresectable, locally advanced non-small-cell lung cancer: a radiation therapy perspective with an emphasis on the trials of the Radiation Therapy Oncology Group. Clinical Lung Cancer 3(3): 191-199, 2003

A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11. Journal of Clinical Oncology 8(9): 1543-1555, 1990

Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. International Journal of Radiation Oncology, Biology, Physics 63(3): 667-671, 2005

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation therapy oncology group protocol 91-06. Journal of Clinical Oncology 14(4): 1055-1064, 1996

Post-operative radiation therapy in locally advanced non-small cell lung cancer and the impact of sequential versus concurrent chemotherapy. Translational Lung Cancer Research 7(Suppl 2): S171-S175, 2018

Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04. International Journal of Radiation Oncology Biology Physics 38(1): 149-155, 1997

Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: Analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. International Journal of Radiation Oncology Biology Physics 27(3): 493-498, 1993

Randomized Trial of Amifostine in Locally Advanced Non-Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiation: Radiation Therapy Oncology Group Trial 98-01. Yearbook of Oncology 2006: 207-208, 2006

Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. Journal of Clinical Oncology 23(10): 2145-2154, 2005

Concurrent hyperfractionated radiation therapy and low dose, daily chemotherapy as an effective and low toxicity approach in locally advanced (stage III) non-small-cell lung cancer. Clinical Lung Cancer 15(3): E31-E32, 2014